Innovating Works

FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON

Inactiva
Mostrando 1 al 20 de 73 resultados
VIDA: VHIO International postDoctoral programme for translAtional research FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON tramitó un HORIZON EUROPE: The proposed VHIO International postDoctoral programme for translAtional research (VIDA) aims at enabling outstanding junior scientists of a...
2024-09-12 - 2029-12-31 | Financiado
SYNTHIA: Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applica... SYNTHIA is an ambitious collaboration between public and private institutions to facilitate the responsible use of Synthetic Data (SD) in he...
2024-08-09 - 2029-08-31 | Financiado
ENCANT: Nanoengineered particles for enhanced cancer radiotherapy AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS tramitó un HORIZON EUROPE: Current cancer research efforts are focused on obtaining targeted therapies, with greater precision, that lead to improved patient survival,...
2024-08-08 - 2026-06-30 | Financiado
TETRIS: Risk assessment Tools for severe side Effects after breasT Radiotherapy radiation safety through b... Radiation protection and safety measures are essential to ensure adequate quality & safety in radiotherapy (RT). Side effects are systematic...
2024-06-28 - 2027-09-30 | Financiado
MYCiMAX: Maximizing the use of a first clinically viable MYC inhibitor FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON tramitó un HORIZON EUROPE: ERC-2023-ADG Even though the MYC oncogene is a most-wanted target in cancer therapy, no MYC inhibitor has yet reached clinical approval. The applicant ha...
2024-04-29 - 2029-04-30 | Financiado
AI4LUNGS: AI-BASED PERSONALISED CARE FOR RESPIRATORY DISEASE USING MULTI-MODAL DATA IN PATIENT STRATIFICATION INESC TEC INSTITUTO DE ENGENHARIADE SISTEMAS E COMPUTADORES TECNOLOGIA E CIENCIA tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-12-two-stage AI4Lungs will develop and validate novel AI-based tools and computational models to improve patient stratification optimising diagnosis and...
2023-12-07 - 2027-06-30 | Financiado
MucOncoBots: Drug loaded nanobots for transmucosal delivery to mucinous tumours FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA tramitó un HORIZON EUROPE: ERC-2023-POC Mucus is a defensive barrier that protects the underlying cells from pathogens and toxic compounds, although it also hinders the delivery of...
2023-09-25 - 2025-03-31 | Financiado
IRB-TARGET: IRB Barcelona International PhD programme on TARGET for high impact biomedicine FUNDACIO INSTITUT DE RECERCA BIOMEDICA IRB BARCELONA tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-COFUND-01 IRB Barcelona (IRB) is an independent, non-profit research centre engaged in basic and applied biomedical science. The IRB-TARGET doctoral p...
2023-09-13 - 2029-08-31 | Financiado
PragmaTIL: Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in sele... FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON tramitó un HORIZON EUROPE: HORIZON-MISS-2022-CANCER-01 The PragmaTIL trial aims to optimize treatment of cancer patients with Tumour-Infiltrating Lymphocytes Adoptive Cell Therapy (TIL-ACT) and s...
2023-04-28 - 2028-03-31 | Financiado
Sagittarius: A PRECISION MEDICINE TRIAL LEVERAGING BLOOD-BASED TUMOR GENOMICS TO OPTIMIZE TREATMENT IN OPERABLE S... IFOMISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS tramitó un HORIZON EUROPE: HORIZON-MISS-2022-CANCER-01 SAGITTARIUS aim to optimize the clinical management of locoregional stage II high-risk/stage III colon cancer (LRCC). Approximately half of...
2023-04-27 - 2028-06-30 | Financiado
MACHETE: Unraveling the Functional Complexity of Cancer Genomes through Chromosome Engineering FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON tramitó un HORIZON EUROPE: ERC-2021-STG Cancers arise through genetic and epigenetic alterations that drive the transformation of single cells into malignant tumors. Among genetic...
2022-12-09 - 2027-12-31 | Financiado
PREVENTABLE: CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE I3S INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-CARE-08 Rare tumour risk syndromes (RTRS) are rare diseases, affecting 5 per 10.000 people or less and caused by heritable genetic variants. In RTRS...
2022-12-02 - 2025-12-31 | Financiado
EOSC4Cancer: A European wide foundation to accelerate Data driven Cancer Research BARCELONA SUPERCOMPUTING CENTERCENTRO NACIONAL DE SUPERCOMPUTACION tramitó un HORIZON EUROPE: HORIZON-INFRA-2021-EOSC-01 Cancer complex nature requires integration of advanced research data across national boundaries to enable progress. Indeed, the Horizon Euro...
2022-06-09 - 2025-02-28 | Financiado
I3LUNG: Integrative science, Intelligent data platform for Individualized LUNG cancer care with Immunotherap... FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-CARE-05 Immunotherapy (IO) is the new standard of care for many patients with advanced Non-Small Cell Lung Cancer (aNSCLC), yet only around 30-50% o...
2022-05-23 - 2027-05-31 | Financiado
CGI-Clinics: Data driven cancer genome interpretation for personalised cancer treatment FUNDACIO INSTITUT DE RECERCA BIOMEDICA IRB BARCELONA tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-CARE-05 CGI-Clinics aims at improving personalised medicine in oncology by optimizing genomic data interpretation (after sequencing and before advis...
2022-05-20 - 2027-10-31 | Financiado
4.UNCAN.eu: A Coordination and Support Action to prepare UNCAN.eu platform INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-MISS-2021-UNCAN-01 The 15-month coordination and support action 4.UNCAN.eu will generate a strategic agenda to launch UNCAN.eu, a European initiative to UNders...
2022-05-17 - 2023-11-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.